Yellow-fever-vaccine

[1]  W. Popp,et al.  Effects of yellow fever vaccination , 2001, The Lancet.

[2]  V. Adhiyaman,et al.  Effects of yellow fever vaccination , 2001, The Lancet.

[3]  F. Laurencet,et al.  Effects of yellow fever vaccination , 2001, The Lancet.

[4]  M. Cetron,et al.  Advanced age a risk factor for illness temporally associated with yellow fever vaccination. , 2001, Emerging infectious diseases.

[5]  T. Monath,et al.  Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases , 2001, The Lancet.

[6]  M. Cetron,et al.  Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases , 2001, The Lancet.

[7]  W. Rawlinson,et al.  Hepatitis and death following vaccination with 17D-204 yellow fever vaccine , 2001, The Lancet.

[8]  J. H. Bauer,et al.  The transmission of yellow fever to Macacus rhesus , 2001 .

[9]  P. Mortimer,et al.  The use of yellow fever virus modified by in vitro cultivation for human immunization , 2000, Reviews in medical virology.

[10]  Matthias Niedrig,et al.  Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection , 1998, Journal of medical virology.

[11]  N. Karabatsos,et al.  First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations. , 1998, The American journal of tropical medicine and hygiene.

[12]  G. Hartmann,et al.  In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination. , 1998, The Journal of infectious diseases.

[13]  T. Monath,et al.  Does restricted distribution limit access and coverage of yellow fever vaccine in the United States? , 1998, Emerging infectious diseases.

[14]  F. Adu,et al.  Live viral vaccine potency: an index for assessing the cold chain system. , 1996, Public health.

[15]  V. Stepanets,et al.  [Effective knowledge propaganda is the chief strategy for preventing HIV infection among adolescents]. , 1994, Likars'ka sprava.

[16]  N. Miller,et al.  Are childhood immunization programmes in Australia at risk? Investigation of the cold chain in the Northern Territory. , 1994, Bulletin of the World Health Organization.

[17]  Iu P Spizhenko [Prevention of the spread of AIDS in the Ukrainian SSR]. , 1988, Vrachebnoe delo.

[18]  E. Schiff,et al.  A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. , 1987, The New England journal of medicine.

[19]  R. A. Morrissey,et al.  Inadequate poliovirus immunity levels in immunized Illinois children. , 1973, American journal of diseases of children.

[20]  J. Fox,et al.  ENCEPHALITIS IN MAN FOLLOWING VACCINATION WITH 17 D YELLOW FEVER VIRUS , 1942 .

[21]  H. H. Smith,et al.  Yellow Fever Vaccination with Cultured Virus (17D) without Immune Serum 1 , 1938 .

[22]  Max Theiler,et al.  THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION , 1937, The Journal of experimental medicine.

[23]  S. Kitchen,et al.  Yellow Fever accidentally Contracted in the Laboratory. A Study of Seven Cases. , 1931 .

[24]  J. H. Bauer,et al.  THE TRANSMISSION OF YELLOW FEVER TO MACACUS RHESUS: PRELIMINARY NOTE , 1928 .